Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

11 April 2024.

The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

Visiongain Publishes Female Health Tech Market Report 2024-2034

5 April 2024.

The global Female Health Tech market was estimated to be valued at US$ 140.9 billion in 2034 and is expected to register a CAGR of 9.6% from 2024 to 2034.

Visiongain Publishes Meningococcal Vaccines Market Report 2024-2034

26 March 2024.

The global Meningococcal Vaccines market is projected to grow at a CAGR of 2.5% by 2034

Visiongain Publishes Medical Imaging Devices Market Report 2024-2034

20 March 2024.

The global Medical Imaging Devices market was valued at US$ 54.3 billion in 2024 and is projected to grow at a CAGR of 4.6% during the forecast period 2024-2034.

Visiongain Publishes Women’s Health Market Report 2024-2034

18 March 2024.

The global Women’s Health market was estimated to be valued at US$ 61 billion in 2034 and is expected to register a CAGR of 4.6% from 2024 to 2034.

Visiongain Publishes Clinical Trial Supplies Market Report 2024-2034

14 March 2024.

The global Clinical Trial Supplies market is estimated at US$4,146.7 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period 2024-2034.

Visiongain Publishes Pre-Filled Syringes Market Report 2024-2034

The global Pre-Filled Syringes market is estimated at US$5,069.3 million in 2024 and is expected to register a CAGR of 9.5% from 2024 to 2034.

Visiongain Publishes Generic Drugs Market Report 2024-2034

The global Generic Drugs market is estimated at US$450.7 billion in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period 2024-2034.

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2024-2034

The global Pharma Wholesale and Distribution market is estimated at US$844.2 billion in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period 2024-2034.

Visiongain Publishes Biobanking Market Report 2024-2034

The global Biobanking market is estimated at US$75.4 billion in 2024 and is projected to grow at a CAGR of 9.1% during the forecast period 2024-2034.

Visiongain Publishes Dermatological Drugs Market Report 2024-2034

The Dermatological Drugs market is estimated at US$30.47 billion in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period 2024-2034.

Visiongain Publishes Allergic Rhinitis Drugs Market Report 2024-2034

The global Allergic Rhinitis Drugs market is estimated at US$16,821.6 million in 2024 and is expected to register a CAGR of 2.7% from 2024 to 2034.

Visiongain Publishes Translational Regenerative Medicine Market Report 2024-2034

The global Translational Regenerative Medicine market is estimated at US$77.93 billion in 2024 and is expected to register a CAGR of 24.3% from 2024 to 2034.

Visiongain Publishes Epilepsy Therapeutics Market Report 2024-2034

The global Epilepsy Therapeutics market is estimated at US$9,858.7 million in 2024 and is projected to grow at a CAGR of 8.1% during the forecast period 2024-2034.

Visiongain Publishes Companion Diagnostics (CDx) Market Report 2024-2034

The global Companion Diagnostics (CDx) market is estimated at US$6,574.6 million in 2024 and is projected to grow at a CAGR of 11% during the forecast period 2024-2034.

Neuromodulation Devices Market Report 2024-2034, Overview of Visiongain’s 251 page report.

The global Neuromodulation Devices market is estimated at US$10,002.7 million in 2024 and is expected to register a CAGR of 12.4% from 2024 to 2034.

Visiongain Publishes Respiratory Drug Delivery Market Report 2024-2034

The global Respiratory Drug Delivery market is estimated at US$67.11 billion in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period 2024-2034.

Visiongain Publishes Pharmaceutical Logistics Market Report 2024-2034

The global Pharmaceutical Logistics Market is estimated at US$93.3 billion in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period 2024-2034.

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2024-2034

The precision cancer diagnostic test market was valued at US$10,623.3 million in 2023 and is projected to grow at a CAGR of 16.1% during the forecast period 2024-2034.

Antibacterial Drugs Market Report 2024-2034

The Antibacterial Drug market was valued at US$ 39,178.7 million in 2024 and is projected to grow at a CAGR of 3.6% during the forecast period 2024-2034.

Clients & Partners

BP logo Kelloggs logo BAE systems logo Unilever logo BASF logo 3M logo THALES logo TEVA logo Shell logo Raytheon logo Pfizer logo Lockhead Martin logo Mercedes logo Honeywell logo DUPONT logo Daimler logo Deloitte logo